]>
IRCT20181130041802N1 IRCT 2019-02-03 Tehran University of Medical Sciences Ghams inferior extremity on knee pain relief Effect of 12 point inferior extremity ghams on knee pain relief 2018-09-22 anticipated 80 Complete https://irct.ir/trial/36577 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: Designed for the first time, Randomization description: A simple randomization, 80 numbers were written on 80 paper and placed inside a bag. The numbers were randomly and blindly removed from the bag. 40 first issues as intervention group and 40 second ones as control group, Blinding description: Both participants, as well as researchers or evaluators, are unaware of the allocation of study groups. 3 Knee Pain. Intervention group:. Yes - There is a plan to make this available What will be shared: All Data When: 6 months after printing results To whom: All People Conditions: Maintaining intellectual rights Where to obtain: Maryam Alinaghizadeh How to obtain: A written request by sending an email and receiving an answer within 10 days Comments:
public Maryam Alinaghizadeh
Unite 1, Floor 8, Baharan Complex, No. 15, Javanshir St.
Tehran Iran (Islamic Republic of) 1668848755 +98 21 2296 4390 forqanimhd@gmail.com Tehran University of Medical Sciences scientific Maryam Alinaghizadeh
Unite 1, Floor 8, Baharan Complex, No. 15, Javanshir St.
Tehran Iran (Islamic Republic of) 1668848755 +98 21 2296 4390 forqanimhd@gmail.com Tehran University of Medical Sciences Iran (Islamic Republic of) Complete vigilance and satisfaction. Age over 35 years old. Diagnosis of osteoarthritis according to the American Society of Rheumatology: Having knee pain and having at least 5 of the 8 cases Not using a variety of complementary therapies during the previous three months Lack of personalized sedative medications and drug by the patient The absence of severe neuropathy in the patient. Healthy areas under massage Lack of mental retardation, blindness and deafness. The absence of rheumatoid arthritis, fibromyalgia, acute or recurrent pseudoravirus, malignancy, internal disease, Such as kidney or liver disorder, gastrointestinal bleeding, asthma requiring corticosteroid administration Non-use of corticosteroid in less than 5 weeks, injection of knee depoocorticosteroid in less than 3 months old or intra-articular hyaluronate in less than 6 months A lack of arthroscopy over the past year No significant damage to the knee in less than 6 months Insensitivity and ulcer in the knee. Ability to learn 12 ghams points 35 years no limit Both Using a variety of complementary therapies during the previous three months Personalized sedative medications and drug by the patient Severe neuropathy in the patient Having mental retardation, blindness and deafness. having the rheumatoid arthritis, fibromyalgia, acute or recurrent pseudoravirus, malignancy, internal disease, Such as kidney or liver disorder, gastrointestinal bleeding, asthma requiring corticosteroid administration Use of corticosteroid in less than 5 weeks, injection of knee depoocorticosteroid in less than 3 months old or intra-articular hyaluronate in less than 6 months Arthroscopy over the past year Significant damage to the knee in less than 6 months Sensitivity and ulcer in the knee M17.9 Osteoarthritis of knee, unspecified Rehabilitation Intervention group: Knee Pain. Timepoint: Before the study 0, Sixth day, Fourteenth day. Method of measurement: Knee injury and Osteoarthritis Outcome Score, Visual Analogue Scale. Diclofenac drug intake. Timepoint: Fourteenth day. Method of measurement: Number. Tehran University of Medical Sciences Approved 2018-08-31 Ethics committee of Tehran University of Medical Sciences Sixth Floor, Central Office of Tehran University of Medical Sciences, Ghodss St., Keshavarz Blvd. Tehran Tehran Iran (Islamic Republic of)